Top Ornithine Transcarbamylase (OTC) Deficiency Treatment Companies

  1. Amgen

  2. Ultragenyx Pharmaceutical Inc.

  3. Zevra Therapeutics

  4. Bausch Health

  5. Danone Group

*Disclaimer: Top companies sorted in no particular order

Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Major Players

Ornithine Transcarbamylase (OTC) Deficiency Treatment - Competitive Concentration

Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Concentration

List of Ornithine Transcarbamylase (OTC) Deficiency Treatment Companies

  • Amgen

  • Bausch Health

  • Ultragenyx Pharmaceutical Inc.

  • Zevra Therapeutics

  • Arcturus Therapeutics Inc.

  • iECURE

  • Danone Group (Nutricia)

  • Abbott Laboratories

  • Nestlé Health Science

  • Reckitt Benckiser Group

  • Moderna

  • Eurocept (Lucane Pharma)

  • UniQure N.V.

  • Astellas Gene Therapies

  • AstraZeneca

  • Asklepios BioPharmaceutical

  • Generation Bio

  • OrphanPacific Inc.

  • Immedica Pharma AB

Get more insights on Ornithine Transcarbamylase (OTC) Deficiency Treatment industry from our comprehensive report